Almkvist O - Search Results

1

Preclinical cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers in Swedish familial Alzheimer's disease.

Thordardottir S, Ståhlbom AK, Ferreira D, Almkvist O, Westman E, Zetterberg H, Eriksdotter M, Blennow K, Graff C. Thordardottir S, et al. Among authors: almkvist o. J Alzheimers Dis. 2015;43(4):1393-402. doi: 10.3233/JAD-140339. J Alzheimers Dis. 2015. PMID: 25182737

2

Amino acid concentrations in cerebrospinal fluid and plasma in Alzheimer's disease and healthy control subjects.

Basun H, Forssell LG, Almkvist O, Cowburn RF, Eklöf R, Winblad B, Wetterberg L. Basun H, et al. Among authors: almkvist o. J Neural Transm Park Dis Dement Sect. 1990;2(4):295-304. doi: 10.1007/BF02252924. J Neural Transm Park Dis Dement Sect. 1990. PMID: 2078309

3

Neuropsychological features of early Alzheimer's disease: preclinical and clinical stages.

Almkvist O. Almkvist O. Acta Neurol Scand Suppl. 1996;165:63-71. doi: 10.1111/j.1600-0404.1996.tb05874.x. Acta Neurol Scand Suppl. 1996. PMID: 8740991 Review.

4

Cerebrospinal fluid levels of alpha-secretase-cleaved soluble amyloid precursor protein mirror cognition in a Swedish family with Alzheimer disease and a gene mutation.

Almkvist O, Basun H, Wagner SL, Rowe BA, Wahlund LO, Lannfelt L. Almkvist O, et al. Arch Neurol. 1997 May;54(5):641-4. doi: 10.1001/archneur.1997.00550170111022. Arch Neurol. 1997. PMID: 9152122

5

Brain volumes and regional cerebral blood flow in carriers of the Swedish Alzheimer amyloid protein mutation.

Julin P, Almkvist O, Basun H, Lannfelt L, Svensson L, Winblad B, Wahlund LO. Julin P, et al. Among authors: almkvist o. Alzheimer Dis Assoc Disord. 1998 Mar;12(1):49-53. doi: 10.1097/00002093-199803000-00008. Alzheimer Dis Assoc Disord. 1998. PMID: 9539411

6

Mild cognitive impairment--an early stage of Alzheimer's disease?

Almkvist O, Basun H, Bäckman L, Herlitz A, Lannfelt L, Small B, Viitanen M, Wahlund LO, Winblad B. Almkvist O, et al. J Neural Transm Suppl. 1998;54:21-9. doi: 10.1007/978-3-7091-7508-8_3. J Neural Transm Suppl. 1998. PMID: 9850912 Review.

7

A follow-up study of the family with the Swedish APP 670/671 Alzheimer's disease mutation.

Wahlund LO, Basun H, Almkvist O, Julin P, Axelman K, Shigeta M, Jelic V, Nordberg A, Lannfelt L. Wahlund LO, et al. Among authors: almkvist o. Dement Geriatr Cogn Disord. 1999 Nov-Dec;10(6):526-33. doi: 10.1159/000017200. Dement Geriatr Cogn Disord. 1999. PMID: 10559570 Clinical Trial.

8

Conversion from preclinical to dinical stage of Alzheimer's disease as shown by decline of cognitive function in carriers of the Swedish APP-mutation.

Almkvist O, Axelman K, Basun H, Wahlund LO, Lannfelt L. Almkvist O, et al. J Neural Transm Suppl. 2002;(62):117-25. doi: 10.1007/978-3-7091-6139-5_12. J Neural Transm Suppl. 2002. PMID: 12456057

9

Cerebral glucose metabolism, cerebrospinal fluid-beta-amyloid1-42 (CSF-Abeta42), tau and apolipoprotein E genotype in long-term rivastigmine and tacrine treated Alzheimer disease (AD) patients.

Stefanova E, Blennow K, Almkvist O, Hellström-Lindahl E, Nordberg A. Stefanova E, et al. Among authors: almkvist o. Neurosci Lett. 2003 Feb 27;338(2):159-63. doi: 10.1016/s0304-3940(02)01384-8. Neurosci Lett. 2003. PMID: 12566177 Clinical Trial.

10

Clinical findings in nondemented mutation carriers predisposed to Alzheimer's disease: a model of mild cognitive impairment.

Almkvist O, Axelman K, Basun H, Jensen M, Viitanen M, Wahlund LO, Lannfelt L. Almkvist O, et al. Acta Neurol Scand Suppl. 2003;179:77-82. doi: 10.1034/j.1600-0404.107.s179.11.x. Acta Neurol Scand Suppl. 2003. PMID: 12603253

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters